Heidi is an Associate at Innosight, based in San Francisco.
Prior to Innosight, Heidi worked in life sciences consulting. She started in scientific and regulatory consulting at Intertek to help biopharma clients navigate the development and approval of drugs and medical devices. Her curiosity in the business aspects of the industry led her to transition to strategy consulting at Coactuate, where she supported biopharma companies with global product launches and strategic planning initiatives at the portfolio level.
Heidi graduated from the University of Toronto with a BSc in Pharmacology and Biomedical Toxicology. During her studies, she completed a one-year research training program under Professor Jeff Karp at Harvard Medical School and co-authored academic papers on stem cell-based therapies.